The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40

Bear, HD; Tang, G; Rastogi, P; Geyer, CE; Zoon, CK; Kidwell, KM; Robidoux, A; Baez-Diaz, L; Brufsky, AM; Mehta, RS; Fehrenbacher, L; Young, JA; Senecal, FM; Gaur, R; Margolese, RG; Adams, PT; Gross, HM; Costantino, JP; Paik, S; Swain, SM; Mamounas, E

Bear, HD (reprint author), NRG Oncol, Pittsburgh, PA 19103 USA.; Bear, HD (reprint author), NSABP, Pittsburgh, PA 15212 USA.; Bear, HD (reprint author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA.

ANNALS OF SURGICAL ONCOLOGY, 2017; 24 (7): 1853

Abstract

NRG Oncology/NSABP trial B-40 tested the impact of adding bevacizumab (bev) to neoadjuvant chemotherapy for operable breast cancer. Secondary endpoint......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索